Chengdu Xinjie High-Tech Development

Chengdu Xinjie High-Tech Development is a pharmaceutical company based in Chengdu, China, specializing in the research, development, and production of chemical drugs and active pharmaceutical ingredients (APIs). As a key subsidiary of China Grand Pharmaceutical and Healthcare Holdings (Grandpharma), the company focuses on cardiovascular, anti-infective, and respiratory therapeutic areas. Its flagship product is Tirofiban Hydrochloride, an anti-platelet medication used for treating acute coronary syndrome. The company operates GMP-certified manufacturing facilities and maintains a robust portfolio of both generic and improved chemical drugs. Chengdu Xinjie serves as a critical production and R&D hub within the Grandpharma group, supporting its expansion in the domestic and international healthcare markets.